Antiviral Discovery for Highly Pathogenic Emerging Viruses

Author:   César Muñoz-Fontela (Bernhard Nocht Institute for Tropical Medicine, Germany) ,  Rafael Delgado (Hospital Universitario 12 de Octubre, Madrid, Spain)
Publisher:   Royal Society of Chemistry
Volume:   Volume 80
ISBN:  

9781788015646


Pages:   308
Publication Date:   08 December 2021
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $411.41 Quantity:  
Add to Cart

Share |

Antiviral Discovery for Highly Pathogenic Emerging Viruses


Add your own review!

Overview

Full Product Details

Author:   César Muñoz-Fontela (Bernhard Nocht Institute for Tropical Medicine, Germany) ,  Rafael Delgado (Hospital Universitario 12 de Octubre, Madrid, Spain)
Publisher:   Royal Society of Chemistry
Imprint:   Royal Society of Chemistry
Volume:   Volume 80
Weight:   0.606kg
ISBN:  

9781788015646


ISBN 10:   1788015649
Pages:   308
Publication Date:   08 December 2021
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets; Advances in Prophylaxis and Therapy of Arenavirus Hemorrhagic Fevers; Vaccines and Antiviral Developments for SARS-CoV-2 in the Emergence of the COVID-19 Pandemic; Small-molecule and Synthetically Derived Antivirals for Ebola Virus and Other Filoviruses; Antiviral Strategies for Ebola Virus and Other Filoviruses: Antibodies; Vaccine Development in the Midst of Ebolavirus Disease Outbreaks; Remdesivir: Investigational Antiviral Drug with Activity Against Ebola and Other Emerging and Neglected Viruses; Therapeutics Against Nipah and Hendra Virus; Glycomimetics as Promising Inhibitors of Ebola Virus, Flavivirus and HIV Infections; Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses; Receptors on Primary Phagocytes as Therapeutic Targets Against Highly Pathogenic Emerging Viruses

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

wl

Shopping Cart
Your cart is empty
Shopping cart
Mailing List